期刊文献+

纳米银对人肺癌A549细胞增殖的影响及其作用机制 被引量:4

Effect of silver nanoparticles on proliferation of human lung cancer A549 cells
暂未订购
导出
摘要 目的探讨纳米银对人肺癌A549细胞毒性的影响及其作用机制。方法通过显微镜观察纳米银对A549细胞形态的变化。MTT法检测不同浓度纳米银对A549细胞增殖的影响。流式细胞仪检测纳米银对A549细胞周期阻滞的影响。Western blot和免疫组织化学法检测纳米银对A549细胞凋亡蛋白表达的影响。结果与对照组比较,随着纳米银药物浓度的增加,A549细胞抑制率显著增加,其半数抑制率为(74.23±4.17)mg/L。纳米银作用于A549细胞G2/M期,纳米银中、高浓度明显上调细胞周期调控p21、p53基因的表达;纳米银可抑制Bcl-2蛋白的表达,对caspase-3有活化作用。结论体外细胞实验证实,纳米银通过抑制A549细胞G2/M期,使p21、p53基因表达紊乱,诱导凋亡因子表达,通过多靶点作用抑制细胞生长。 Objective To investigate the effect of silver nanoparticles on the proliferation of human lung carcinoma A549 cells and its mechanism. Methods Cultured A549 ceils were treated with different concentrations of silver nanoparticles in vitro. The morphological change of A549 cells was observed by microscopy. Cell proliferation was determined by MTT assay. Cell cycle was examined by flow cytometry and the expression of p21, p53, Bcl-2 and caspase-3 proteins was detected by Western blot and immunohistochemistry. Results Compared with control group, the inhibition of A549 cells was significantly increased as the concentration of silver nanoparticles increased [ IC50 = ( 74.23 ± 4.17 ) mg/L ]. After silver nanoparticle treatment,cell cycle was arrested in Gz/M phase; the expression of p21 ,p53 and caspase-3 was increased and the expression of Bcl-2 was decreased. Conclusion Silver nanoparticles can inhibit the proliferation of A549 cells,which is associated with the blockage in G2/M phase, the up-regnlation of p21, p53 and caspase-3 expression, and the down-regulation of Bcl-2 expression.
出处 《实用肿瘤杂志》 CAS 2014年第2期148-152,共5页 Journal of Practical Oncology
关键词 细胞系 肿瘤 病理学 纳米结构 治疗应用 治疗应用 细胞增殖 药物作用 细胞凋亡 G2期 lung neoplasms/pathology cell line, tumor/drug effects cell line, tumor/pathology nanostructures/ therapeutic use silver/therapeutic use cell proliferation/drug effects apoptosis G2 phase
  • 相关文献

参考文献15

  • 1张月,周颖,刘真,方唯意.CDK4蛋白在胞浆中的表达与肺癌临床病理学特征及预后的关系[J].南方医科大学学报,2012,32(11):1572-1575. 被引量:4
  • 2Shanmugasundaram T, Radhakrishnan M, Gopikrishnan V, et al. A study of the bactericidal, anti-biofouling, cytotoxic and antioxidant properties of actinobacterially synthesised silver nanoparticles[J]. Colloids Surf B Biointerfaces,2013,23(3) :209 -216.
  • 3Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance[J]. Adv Drug Deliv Rev ,2013 ,29( 12) : 165 -169.
  • 4向冬喜,蒋晓婷,李秀景,尹俭俭,陈娜娜,尹蕾,郑丛龙.纳米银体外抗H3N2流感病毒作用及其机制初步探讨[J].华西医学,2011,26(1):4-7. 被引量:4
  • 5尹俭俭,李秀景,郑丛龙.纳米银抗3型副流感病毒作用及机制研究[J].江苏大学学报(医学版),2013,23(3):191-196. 被引量:4
  • 6Lu L, Sun RWY, Chen R, et al. Silver nanoparticles inhibit hepatitis B virus replication[J]. Antivir Ther, 2008,13(2) :253 -262.
  • 7Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, et al. Mode of antiviral action of silver nanoparticles against HIV-l[J].J Nanobiotechnol ,2010,8 (1) : 1121 - 1130.
  • 8ElechiguerraJL, BurtJL, MoronesJR, et al. Interaction of silver nanoparticles with HIV -I[J].J Nanobiotechnol, 2005,3 (l) :6 - 16.
  • 9Asharani PV, Hande MP, Valiyaveettil S. Anti?proliferative activity of silver nanoparticles[J] . BMC Cell Bioi ,2009, 1O( 1 ) :65 - 70.
  • 10Powers CM, Badireddy AR, Ryde IT, et al. Silver nanoparticles compromise ueurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating, and composition[J] . Environ Health Perspect, 2011 ,119(1) :37 -44.

二级参考文献56

共引文献25

同被引文献40

  • 1周竞峥,付玲,罗玲,刘勇.癌症恶病质的中西医诊治现状[J].中医肿瘤学杂志,2019,0(5):82-85. 被引量:12
  • 2Roebuck D J, Perilongo G. Hepatoblastoma: an oncologi- cal review [ J ]. Pediatr Radiol, 2006,36 ( 3 ) : 183 - 186.
  • 3Litten JB,Tomlinson GE. Liver tumors in children [ J ]. Oneologist, 2008,13 ( 7 ) : 812 - 820.
  • 4Ansell P, Mitchell CD, Roman E,et al. Relationships be- tween perinatal and maternal characteristics and hepato- blastoma: a report from the UKCCS[ J]. Eur J Cancer, 2005,41 (5) : 741 - 748.
  • 5Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy [ J ]. Hepatology, 2000, 31 (4) : 1019 - 1021.
  • 6Brnix J, Gores GJ, Mazzaferro V. Hepatoceilular carcino-ma: clinical frontiers and perspectives[ J]. Gut,2014,63 (5) :844 -855.
  • 7Nabavi SF, Di Lorenzo A, Izadi M, et al. Antibacterial effects of cinnamon: From farm to food, cosmetic and pharmaceutical industries [ J ]. Nutrients, 2015,7 ( 9 ) : 7729 - 7748.
  • 8Hafizur RM, Hameed A, Shukrana M, et al. Cinnamie acid exerts anti-diabetic activity by improving glucose tol- erance in vivo and by stimulating insulin secretion in vitro [ J ]. Phytomedicine, 2015,22 (2) : 297 - 300.
  • 9Hagenlocher Y, Kiel31ing K, Sch/iffer M, et al. Cinnamal- dehyde is the main mediator of cinnamon extract in mast cell inhibition [ J ]. Eur J Nutr, 2015,54 ( 8 ) : 1297 - 1309.
  • 10Bae WY, Choi JS, Kim JE, et al. Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-lc~ expression during tumor progression[ J]. Biochem Pharmaco1,2015,98 ( 1 ) :41 - 50.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部